KLK3 and prostate cancer: Overall, men with GG 1 disease and a PSA 10–15 ng/mL and PSA density <0.15 ng/mL/cm3 did not significantly differ in upgrading or adverse pathology findings compared to men with NCCN low-risk prostate cancer [13].